logo

IPA

Immunoprecise
--
--(--)
Market Open: --
--
--(--)
Post-Market: --

IPA fundamentals

Immunoprecise (IPA) expects to report earnings on Aug 4, 2025, with estimated revenue of 5.82M (YoY 0.00%), and EPS at -- (YoY 0.00%).
Revenue estimate / YoY
5.82M
0.00%
EPS estimate / YoY
--
0.00%
Report date
Aug 4, 2025
EPS
Revenue

Revenue & Expenses

IPA has released its 2025 Q3 earnings report, with revenue of 4.25M, reflecting a YoY change of -8.48%, and net profit of -14.88M, showing a YoY change of -643.60%. The Sankey diagram below clearly presents IPA's revenue sources and cost distribution.

Key Indicators

Immunoprecise (IPA) key financial stats and ratios, covering profitability, financial health, and leverage.
Immunoprecise (IPA)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Immunoprecise (IPA)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Immunoprecise (IPA)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Immunoprecise (IPA) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Immunoprecise (IPA) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield